OTHERopen🌐 Canada (CanadaBuys)WS5872093541-Doc5872241906
ACAN Vaccinia Immunoglobulin intravenous (human) - VIGIV
Department of Public Works and Government Services (PSPC) / Public Health Agency of Canada (PHAC)
All open bids & awards from Department of Public Works and Government Services (PSPC) →
Description
Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier. Purpose of this Advanced Contract Award Notice (ACAN): Public Services and Procurement Canada proposes to negotiate a contract with Emergent BioSolutions Canada Inc on behalf of Public Health Agency of Canada (PHAC). Requirement description: Public Health Agency of Canada (PHAC) has a requirement for vaccinia Immunoglobulin intravenous (human) (VIGIV) to protect against complications from vaccination with live-replicating smallpox vaccines containing vaccinia virus.
Details?
- Posted
- Sep 10, 2026
- Response deadline
- Sep 30, 2026, 2:00 PM UTC (18d)
- Type
- OTHER
- Procurement method
- Advance contract award notice
- Status
- Open
- Commodity code
- *51000000
- Trade agreements
- *Canada-Colombia Free Trade Agreement *Canada-Peru Free Trade Agreement (CPFTA) *Canada-UK Trade Continuity Agreement (Canada-UK TCA) *World Trade Organization Agreement on Government Procurement (WTO
- Buyer
- Department of Public Works and Government Services (PSPC)
- Department
- Public Health Agency of Canada (PHAC)
- Jurisdiction
- Canada (CanadaBuys)
- Location
- *Canada
- Reference #
- WS5872093541-Doc5872241906
- Solicitation #
- WS5872093541
- Has Description
- true
- Amendments
- 0
- Last amended
- Sep 10, 2026
- Country
- Canada
- Unspsc Description
- *Drugs and Pharmaceutical Products
- Amendment Number
- 000
- Selection Criteria
- Not applicable
- Tender Description
- Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award
- Limited Tendering Reason
- Exclusive Rights
- End User Entities Address
- 130 Colonnade Road,Ottawa,Ontario,K1A 0K9,Canada
- Contracting Entity Address City
- Gatineau
- Contracting Entity Address Line
- 11 Laurier St, Phase III, Place du Portage
- Contracting Entity Address Postal Code
- K1A 0S5
- Contracting Entity Address Province
- Quebec
Contact
Ramenason, Anja (SPAC/PSPC)
anja.ramenason@tpsgc-pwgsc.gc.caSimilar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 118,000+ open bids from 2,400+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from Canada (CanadaBuys)'s open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.